|
TTYH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.655500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.590400E-02 |
| Normal-vs-Stage2 |
2.293900E-02 |
| Normal-vs-Stage3 |
1.154040E-02 |
| Normal-vs-Stage4 |
7.472400E-02 |
| Stage1-vs-Stage2 |
4.169800E-01 |
| Stage1-vs-Stage3 |
8.248200E-02 |
| Stage1-vs-Stage4 |
4.721800E-01 |
| Stage2-vs-Stage3 |
2.706200E-01 |
| Stage2-vs-Stage4 |
9.015600E-01 |
| Stage3-vs-Stage4 |
5.210400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.857650E-03 |
| Normal-vs-AfricanAmerican |
2.372400E-01 |
| Normal-vs-Asian |
8.871200E-01 |
| Caucasian-vs-AfricanAmerican |
5.741700E-02 |
| Caucasian-vs-Asian |
1.990370E-01 |
| AfricanAmerican-vs-Asian |
4.731000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.764000E-03 |
| Normal-vs-Female |
3.203700E-02 |
| Male-vs-Female |
5.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.566100E-02 |
| Normal-vs-Extreme_Weight |
8.040300E-02 |
| Normal-vs-Obese |
3.982100E-03 |
| Normal-vs-Extreme_Obese |
1.711770E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.732200E-01 |
| Normal_Weight-vs-Obese |
3.655600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.152400E-01 |
| Extreme_Weight-vs-Obese |
7.323900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.012750E-01 |
| Obese-vs-Extreme_Obese |
8.090600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.389900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.581100E-04 |
| Normal-vs-Age(61-80Yrs) |
8.029700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.421600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.283400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.323600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.388020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.536400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.287600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.656000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.309880E-02 |
| Normal-VS-Type2 PRCC |
1.055910E-02 |
| Normal-VS-KIRP CIMP |
1.655830E-02 |
| Normal-VS-Unclassified PRCC |
4.877500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.394400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.098200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.702150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.959700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.914600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.256300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.457900E-02 |
| Normal-vs-N1 |
8.037600E-03 |
| Normal-vs-N2 |
1.604080E-03 |
| N0-vs-N1 |
1.342570E-01 |
| N0-vs-N2 |
8.450400E-02 |
| N1-vs-N2 |
6.391200E-01 |
|
|
